Colorectal cancer statistics, 2020

Ca-A Cancer Journal for Clinicians - Tập 70 Số 3 - Trang 145-164 - 2020
Rebecca L. Siegel1, Kimberly D. Miller1, Ann Goding Sauer1, Stacey A. Fedewa1, Lynn F. Butterly2,3, Joseph C. Anderson4,3, Andrea Cercek5, Robert A. Smith6, Ahmedin Jemal1
1Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia
2Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire
3The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
4Department of Veterans Affairs Medical Center, White River Junction, Vermont
5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
6Cancer Control Department, American Cancer Society, Atlanta, Georgia

Tóm tắt

AbstractColorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC occurrence based on incidence data (available through 2016) from population‐based cancer registries and mortality data (through 2017) from the National Center for Health Statistics. In 2020, approximately 147,950 individuals will be diagnosed with CRC and 53,200 will die from the disease, including 17,930 cases and 3,640 deaths in individuals aged younger than 50 years. The incidence rate during 2012 through 2016 ranged from 30 (per 100,000 persons) in Asian/Pacific Islanders to 45.7 in blacks and 89 in Alaska Natives. Rapid declines in incidence among screening‐aged individuals during the 2000s continued during 2011 through 2016 in those aged 65 years and older (by 3.3% annually) but reversed in those aged 50 to 64 years, among whom rates increased by 1% annually. Among individuals aged younger than 50 years, the incidence rate increased by approximately 2% annually for tumors in the proximal and distal colon, as well as the rectum, driven by trends in non‐Hispanic whites. CRC death rates during 2008 through 2017 declined by 3% annually in individuals aged 65 years and older and by 0.6% annually in individuals aged 50 to 64 years while increasing by 1.3% annually in those aged younger than 50 years. Mortality declines among individuals aged 50 years and older were steepest among blacks, who also had the only decreasing trend among those aged younger than 50 years, and excluded American Indians/Alaska Natives, among whom rates remained stable. Progress against CRC can be accelerated by increasing access to guideline‐recommended screening and high‐quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle‐aged adults.

Từ khóa


Tài liệu tham khảo

10.3322/caac.21440

10.1016/S1052-5157(03)00053-9

Surveillance, Epidemiology, and End Results (SEER) Program, 2019, SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence–CiNA Analytic File, 1995‐2016, for NHIAv2 Origin, Custom File With County, ACS Facts and Figures projection Project

Surveillance, Epidemiology, and End Results (SEER) Program, 2019, SEER*Stat Database: Incidence‐SEER 9 Regs Research Data With Delay Adjustment, Nov. 2018 Sub (1975‐2016) <Katrina/Rita Population Adjustment>‐Linked To County Attributes‐Total US, 1969‐2017 Counties

Surveillance, Epidemiology, and End Results (SEER) Program, 2019, SEER*Stat Database: Incidence‐SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov. 2018 Sub (2000‐2016)‐Linked To County Attributes‐Total US, 1969‐2017 Counties

Howlader N, 2019, SEER Cancer Statistics Review, 1975‐2016

Surveillance, Epidemiology, and End Results (SEER) Program, 2019, SEER*Stat Database: Mortality‐All COD, Aggregated With State, Total US (1969‐2017) <Katrina/Rita Population Adjustment>

10.1002/cncr.11380

Centers for Disease Control and Prevention.Behavioral Risk Factor Surveillance System Survey Data. Accessed September 4 2019.cdc.gov/brfss/

Centers for Disease Control and Prevention, 2012, Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates, MMWR Morb Mortal Wkly Rep., 61, 410

National Center for Health Statistics, Division of Health Interview Statistics, 2019, National Health Interview Survey Public Use Data File 2018

10.1002/cncr.27404

10.1002/cncr.27405

10.3322/caac.21590

Percy C, 2000, International Classification of Diseases for Oncology

10.1093/jnci/djr207

Surveillance, Epidemiology, and End Results (SEER) Program, 2019, SEER*Stat software

Surveillance, Epidemiology, and End Results (SEER) Program, 2019, SEER*Stat Database: National Program of Cancer Registries (NPCR) and SEER Incidence‐US Cancer Statistics (USCS) file for Delay Adjustment‐1999‐2016‐jbk 072919

10.1093/jnci/94.20.1537

Statistical Research and Applications Branch, National Cancer Institute, 2019, Joinpoint Regression Program. Version 4.7.0.0

Statistical Research and Applications Branch, National Cancer Institute, 2019, DevCan—Probability of Developing or Dying of Cancer Software. Version 6.7.7

10.1093/jnci/djw322

10.1002/ijc.10635

10.1111/j.1440-1746.2007.04923.x

10.1016/j.ejso.2014.11.001

10.1093/jnci/dju427

10.1002/ijc.30527

10.1056/NEJMoa042990

10.1158/1055-9965.EPI-05-0678

10.1002/ijc.25481

10.1053/j.gastro.2019.10.029

Semega J, 2019, P60‐266. Income and Poverty in the United States: 2018

10.1002/cncr.26677

10.1093/jnci/djs346

10.1158/1055-9965.EPI-12-0023

10.7326/M16-1154

10.1093/jnci/djq068

10.1007/s10552-014-0344-z

10.1007/s40615-015-0174-z

10.1053/j.gastro.2017.11.005

10.1158/1055-9965.EPI-09-0211

10.3322/caac.21335

10.1016/j.jss.2019.07.004

Kelly JJ, 2012, Colorectal cancer in Alaska Native people, 2005‐2009, Gastrointest Cancer Res., 5, 149

10.2105/AJPH.2013.301654

10.1017/S0950268815001181

10.1038/ajg.2012.407

10.1053/j.gastro.2018.09.054

10.1007/s10620-010-1528-3

10.1016/j.amjsurg.2019.09.027

10.1158/1055-9965.EPI-17-0488

10.1016/j.amjmed.2016.07.028

10.1016/j.gie.2011.12.031

10.1136/gutjnl-2015-310912

10.3322/caac.20121

10.1002/cncr.24760

10.1016/S1542-3565(03)00294-5

10.1097/01.mlr.0000246612.35245.21

10.1016/j.amepre.2009.03.009

10.1146/annurev.pu.12.050191.002233

10.1016/S2468-1253(19)30147-5

10.1007/s10552-013-0321-y

10.1136/gutjnl-2019-319511

10.1136/gutjnl-2018-317592

10.1136/gutjnl-2014-309086

10.1093/oxfordjournals.aje.a116143

Ang CSP, 2018, Genomic landscape of appendiceal neoplasms, JCO Precision Oncol., 2, 1

10.1002/cncr.10589

10.1038/s41379-018-0003-0

10.1245/s10434-010-0985-4

American Joint Commission on Cancer, 2010, Summary of Changes: Understanding the Changes from the Sixth to the Seventh Edition of the AJCC Staging Manual

Bosman FT, 2010, WHO Classification of Tumours of the Digestive System

North American Association of Central Cancer Registries ICD‐O‐3 Update Implementation Work Group.Guidelines for ICD‐O‐3 Update Implementation. Effective January 1 2019. Accessed December 31 2019.naaccr.org/wp-content/uploads/2019/12/ICD-O-3-Implementation-Guide-FINAL.pdf

10.1007/s11605-014-2726-7

10.1007/s00384-013-1714-9

10.1001/archsurg.137.7.799

10.1007/s10620-015-3600-5

10.1158/1055-9965.EPI-17-0219

10.1155/2017/2819372

10.1016/j.pmedr.2019.100896

10.1177/0969141319859608

10.3322/caac.21457

Fedewa SA, 2019, Colorectal cancer screening patterns after the American Cancer Society's recommendation to initiate screening at age 45 years, Cancer

10.5888/pcd12.140533

10.3322/caac.21565

10.1007/s11606-018-4648-7

10.3322/canjclin.54.2.78

10.1001/jama.287.16.2106

10.1200/JCO.2017.74.2049

10.1093/jnci/djz135

10.1093/jnci/djr310

10.1093/jnci/djv229

10.1002/cncr.27755

10.1093/jnci/djv198

10.1056/NEJM198506203122504

10.1200/JCO.2007.14.5631

10.1093/jnci/86.13.997

10.1001/jama.296.23.2815

10.1056/NEJM200007203430301

10.1016/j.jss.2015.10.021

10.1002/jso.21864

10.1016/j.critrevonc.2016.11.005

10.1093/jnci/djx015

10.1200/JCO.2008.20.5278

10.1002/cncr.32163

10.1016/j.suronc.2018.05.012

10.1001/jamasurg.2018.0996

Thông tin
Thông tin xuất bản

Ca-A Cancer Journal for Clinicians

Tập 70 Số 3

145-164

Thông tin tác giả